Rogers Michael W
SEC-identified person · CIK 1244159 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Akebia Therapeutics, Inc. AKBA | Director | filed 2018 - 2026 |
| Versartis, Inc. VSAR | Director | filed 2020 - 2022 |
| Psivida LTD PSDV | Director | filed 2007 - 2019 |
| Zeta Acquisition Corp II WHWK | See Remarks | filed 2017 - 2019 |
| Keryx Biopharmaceuticals INC KERX | Director | filed 2016 - 2018 |
| Acorda Therapeutics, Inc. ACOR | Chief Financial Officer | filed 2013 - 2016 |
| Fortress Biotech, Inc. [CNDO] | Director | filed 2011 - 2013 |
| BG Medicine, Inc. BGMD | EVP, CFO and Treasurer | filed 2011 - 2012 |
| Indevus Pharmaceuticals INC IDEV | Executive Vice President | filed 2006 - 2009 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.